BACKGROUND:Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory failure. METHODS:In this multicenter, open-label trial, we randomly assigned patients who had acute hypoxemic respiratory failure to receive high-flow-oxygen or standard-oxygen therapy. All the patients had a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen of 200 or less, a respiratory rate of more than 25 breaths per minute, and pulmonary infiltrate on chest imaging. The primary outcome was death by day 28. RESULTS:A total of 1116 patients underwent randomization. Of these patients, 1110 (556 in the high-flow-oxygen group and 554 in the standard-oxygen group) were included in the analysis. Mortality at day 28 was 14.6% (in 81 of 556 patients) in the high-flow-oxygen group and 14.6% (in 81 of 554 patients) in the standard-oxygen group (difference, -0.05 percentage points; 95% confidence interval [CI], -4.21 to 4.10; P = 0.98). The incidence of intubation by day 28 was 42.4% (in 236 of 556 patients) in the high-flow-oxygen group and 48.4% (in 268 of 554 patients) in the standard-oxygen group (difference, -5.93 percentage points; 95% CI, -11.78 to -0.08). Serious adverse events (cardiac arrest or pneumothorax) occurred during spontaneous breathing in 13 patients (2.3%) in the high-flow-oxygen group and in 6 patients (1.1%) in the standard-oxygen group. CONCLUSIONS:Among patients with acute hypoxemic respiratory failure, the use of oxygen delivered through a high-flow nasal cannula did not significantly reduce mortality at day 28. (Funded by the French Ministry of Health and Fisher and Paykel Healthcare; SOHO ClinicalTrials.gov number, NCT04468126.).
OBJECTIVES:Using network analysis, which takes a holistic approach to health systems, we aimed to identify which psychosocial burden dimensions are the most central and, thus, critical to prioritising to improve the overall health of people with type 1 diabetes (PwT1D). DESIGN:A cross-sectional network analysis. SETTING:We used data from participants attending 44 diabetes centres in France, who were enrolled in the SFDT1 cohort study between June 2020 and February 2024. PARTICIPANTS:We included 1430 PwT1D (52% women, median age (IQR) 41 (31-52.8) years) who had completed questionnaires on diabetes burden. OUTCOME MEASURES:The items from questionnaires on diabetes distress, fear of hypoglycaemia, quality of life, treatment burden and the impact of diabetes on education and work. RESULTS:The network was highly stable (correlation stability coefficient=0.75). We observed nine domains within the network; 'Loneliness, Worrying & Burnout' was the most influential. We further grouped the domains into three distinct syndromes labelled 'Diabetes Distress', 'Treatment Burden' and 'Impact of Diabetes on Life'. These syndromes reflect the most relevant pillars of the psychosocial burden in PwT1D. CONCLUSIONS:We observed that 'Loneliness, Worrying & Burnout' is the most influential psychosocial burden network domain to prioritise for type 1 diabetes care. This new network-based approach opens the path to defining personalised interventions targeting the most critical burden parameters to expect the most significant overall beneficial impact on PwT1D's health. TRIAL REGISTRATION NUMBER:NCT04657783.
The management of HIL indices (Hemolysis, Icterus, Lipemia) remains heterogeneous among clinical chemistry laboratories, despite their major impact on result interpretation. Based on recommendations from the IFCC and the EFLM, a review of the literature, and expert opinions, the French Collège National de Biochimie des Hôpitaux (CNBH) proposes in this document a structured framework aimed at harmonizing practices. These recommendations address the three phases of the total testing process: (1) pre-analytical measures intended to prevent interferences related to sample collection, transport, and preparation; (2) analytical guidelines to better understand the limitations of measurement methods, strengthen quality control, and secure the interpretation of HIL indices; and (3) a standardized post-analytical strategy integrating the definition of thresholds based on potential clinical impact and harmonized communication of results. This document aims to support laboratory professionals in rationalizing and securing the management of HIL indices, thereby improving result quality and clinical management.
Background and ObjectivesDevelopmental and epileptic encephalopathies (DEEs) with early burst-suppression EEG (EIDEE-BS) are among the most severe neonatal epileptic syndromes, typically presenting in the first months of life with refractory seizures and profound neurodevelopmental impairment. Although variants in the KCNQ2, STXBP1, and SCN2A genes are recognized as major causes, the full genetic spectrum remains uncertain. We aimed to delineate the electroclinical characteristics, genetic etiologies, and long-term outcomes in a large MRI-negative EIDEE-BS cohort.MethodsWe retrospectively analyzed 110 patients with BS EEG enrolled from a database of 1,540 individuals with suspected genetic epilepsies (2008-2023). Clinical, EEG, and genetic data were systematically collected. Patients were stratified into 4 groups: KCNQ2, STXBP1, "other pathogenic variants," and "without a genetic diagnosis." EEG traces were reviewed independently, and outcomes were assessed through long-term follow-up.ResultsPathogenic or likely pathogenic variants were identified in 62.7% of patients and involved 23 genes, including 2 copy number variants. KCNQ2 (n = 24) and STXBP1 (n = 16) accounted for one-third of diagnoses, whereas SCN2A (n = 3) and KCNT1 (n = 2) were less frequent. In KCNQ2 cases, seizures and BS onset occurred earlier than in STXBP1 cases: mean 2 days vs 6 weeks for seizures and 3 days vs 2 months for BS, respectively. A typical BS pattern (bursts longer than suppressions) strongly correlated with KCNQ2 and STXBP1 variants. Novel associations were found with DPM1, GRIN2A, KCNT2, PIGO, PURA, WWOX, and candidate genes (KMT2E, SNAP25, and SYT1). Most variants were de novo heterozygous; however, recessive and X-linked inheritance patterns were also observed. Mortality was high (25%), primarily from status epilepticus and complications of severe disability. Most patients (72.5%) had persistent seizures at follow-up (a mean of 6.5 years), as well as profound intellectual disabilities, irrespective of genotype.DiscussionThis large series highlights the strong monogenic basis of EIDEE-BS. KCNQ2, STXBP1, and SCN2A were the most commonly affected genes. Early EEG features, particularly BS timing and morphology, can help anticipate the underlying genotype and guide precision therapy, including the early use of sodium channel blockers in selected cases. These findings support recent ILAE reclassification efforts and underscore the importance of comprehensive genomic testing for improved diagnosis and counseling.
PURPOSE:To set national dose interventional reference levels (IRLs) for adults undergoing the most common cardiac electrophysiology and pacing procedures. MATERIALS AND METHODS:A national multicentre survey was performed in 33 French cardiac electrophysiology and pacing departments. Eleven standard image-guided interventional procedures in cardiac electrophysiology and pacing were analysed. Air Kerma (AK), kerma-area product (PKA) and fluoroscopy time (T) were recorded for 10 to 30 patients per procedure and per centre. IRLs were calculated as the 3rd quartiles and medians of distributions. RESULTS:A total of 4219 patients (70.4 ± 14.4 years old, 32% women) were included. IRLs were suggested for three dosimetric indicators in the eleven procedures. For endovascular implantation (pacemaker and defibrillator), IRLs increased with the complexity of procedures. In terms of PKA and T, IRLs were 4.10 Gy.cm2 and 5.5 min for single-chamber pacemakers, 11.50 Gy.cm2 and 16.5 min for bi-ventricular pacemakers, 2.25 Gy.cm2 and 4.0 min for single-chamber defibrillators and 12.90 Gy.cm2 and 18.0 min for bi-ventricular defibrillators. For all pacemaker procedures, left bundle branch area pacing significantly increased PKA, AK, and T values (p < 0.05). For ablations, the lowest IRLs were found for accessory pathway ablation (4.10 Gy.cm2 and 10.5 min) and the highest for ablation of persistent atrial fibrillation (12.65 Gy.cm2 and 15.5 min). For all ablations, the main energy source used was radiofrequency (>75% of procedures). For most procedures, the IRLs proposed were close to most of those already published, or lower. CONCLUSION:This national multicentre study reports IRLs for the most common image-guided interventional cardiac electrophysiology and pacing procedures.